$0.78
0.00 (0%)
Replidyne, Inc. (NASDAQ:RDYN.DL)
CAPS Rating:
The Company is a biopharmaceutical company focused on discovering, developing, in-licensing and commercializing innovative anti-infective products.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
No players have picked RDYN.DL yet. Tell us why you think RDYN.DL will outperform or underperform the market.
RSS Headlines
Fool UK
